Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Foley

Showing results (611-620 of 911) with videos related to

Pageof 92
Sort By:
Annals of Vascular Surgery|May 9, 2017
Treating Peripheral Artery Disease in the Wake of Rising Costs and Protracted Length of StayGrace J Wang, Benjamin M Jackson, Paul J Foley, et al.
Dalton Transactions (Cambridge, England : 2003)|March 31, 2022
Probing the hydrolytic degradation of UF<sub>4</sub> in humid airBryan J Foley, Jonathan H Christian, Christopher A Klug, et al.
Biochemical Pharmacology|July 6, 1993
Association between leukotriene B4-induced phospholipase D activation and degranulation of human neutrophilsH L Zhou, M Chabot-Fletcher, J J Foley, et al.
Palliative Medicine|September 30, 2016
Palliative care for Parkinson's disease: Patient and carer's perspectives explored through qualitative interviewSiobhan Fox, Alison Cashell, W George Kernohan, et al.
Journal of Medicinal Chemistry|January 1, 1984
Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensineP A Dandridge, C Kaiser, M Brenner, et al.
Cancer|April 6, 2006
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trialElizabeth A Mittendorf, Catherine E Storrer, Rebecca J Foley, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell functionH M Sarau, J A Rush, J J Foley, et al.
The Milbank Memorial Fund Quarterly. Health and Society|January 1, 1985
Epidemiology of disability in the oldest old: methodologic issues and preliminary findingsJ C Cornoni-Huntley, D J Foley, L R White, et al.
Applied Spectroscopy|December 4, 2022
Diffuse Reflectance Spectroscopy and Principal Component Analysis to Retrospectively Determine Production History of Plutonium DioxideEliel Villa-Aleman, Jonathan H Christian, Jason R Darvin, et al.
British Journal of Pharmacology|May 29, 2003
The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptorsChristopher L Herold, David J Behm, Peter T Buckley, et al.
Pageof 92

Showing results (611-620 of 911) with videos related to

Sort By:
Pageof 92
Annals of Vascular Surgery|May 9, 2017
Treating Peripheral Artery Disease in the Wake of Rising Costs and Protracted Length of StayGrace J Wang, Benjamin M Jackson, Paul J Foley, et al.
Dalton Transactions (Cambridge, England : 2003)|March 31, 2022
Probing the hydrolytic degradation of UF<sub>4</sub> in humid airBryan J Foley, Jonathan H Christian, Christopher A Klug, et al.
Biochemical Pharmacology|July 6, 1993
Association between leukotriene B4-induced phospholipase D activation and degranulation of human neutrophilsH L Zhou, M Chabot-Fletcher, J J Foley, et al.
Palliative Medicine|September 30, 2016
Palliative care for Parkinson's disease: Patient and carer's perspectives explored through qualitative interviewSiobhan Fox, Alison Cashell, W George Kernohan, et al.
Journal of Medicinal Chemistry|January 1, 1984
Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensineP A Dandridge, C Kaiser, M Brenner, et al.
Cancer|April 6, 2006
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trialElizabeth A Mittendorf, Catherine E Storrer, Rebecca J Foley, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell functionH M Sarau, J A Rush, J J Foley, et al.
The Milbank Memorial Fund Quarterly. Health and Society|January 1, 1985
Epidemiology of disability in the oldest old: methodologic issues and preliminary findingsJ C Cornoni-Huntley, D J Foley, L R White, et al.
Applied Spectroscopy|December 4, 2022
Diffuse Reflectance Spectroscopy and Principal Component Analysis to Retrospectively Determine Production History of Plutonium DioxideEliel Villa-Aleman, Jonathan H Christian, Jason R Darvin, et al.
British Journal of Pharmacology|May 29, 2003
The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptorsChristopher L Herold, David J Behm, Peter T Buckley, et al.
Pageof 92